CD274 and neoplasm: Notably, deficient mismatch repair (dMMR)/microsatellite instability-high (MSI-H) tumours, characterized by a high mutational burden and abundant neoantigens, demonstrate significantly improved responses to PD-1/PD-L1 blockade [23].